New prostate cancer drug encourages development of treatment pathway. | Manag Care;20(6): 53-4, 2011 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

New prostate cancer drug encourages development of treatment pathway.

Morrow, Thomas.

Affiliation

Morrow T; TMorrow@ManagedCareMag.com

Manag Care ; 20(6): 53-4, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21739927

Subject(s)

Prostatic Neoplasms/drug therapy; Clinical Trials, Phase III as Topic; Drugs, Investigational; Humans; Male; Managed Care Programs; Steroid 17-alpha-Hydroxylase/therapeutic use; United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: Manag Care Journal subject: HOSPITAIS / SERVICOS DE SAUDE Year: 2011 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: Manag Care Journal subject: HOSPITAIS / SERVICOS DE SAUDE Year: 2011 Document type: Article Country of publication: United States